AVO vs COUR

The company exhibits a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability. Despite this, Mission Produce has demonstrated strong recent earnings surprises and positive short-term momentum, with a bullish analyst recommendation and significant EPS growth acceleration. However, declining revenue, low profitability margins, and lack of Altman Z-Score data raise concerns about long-term sustainability. The stock trades above its Graham Number of $9.96 at $13.46, suggesting potential overvaluation relative to defensive value standards, though forward P/E of 16.72 implies improving earnings expectations.

COUR presents a stark divergence between fundamental value and market momentum. While the Piotroski F-Score of 6/9 indicates stable financial health and the balance sheet is exceptionally clean (Debt/Equity 0.01), the stock is in a severe technical collapse with a 0/100 trend score. Despite a low Price/Sales ratio of 1.18 and a bullish analyst target of $9.55, the combination of negative profit margins, decelerating revenue growth (9.9%), and bearish insider selling suggests the market is pricing in a structural decline.